Key result
A survey of 51 cardiologists found that 53% advised driving cessation only for patients with arrhythmia-induced presyncope or collapse, while 43% advised all implanted patients to cease driving.
Why the study?
What are the present practices and criteria utilized by cardiologists regarding driving restrictions for patients with implanted cardioverter defibrillators?
Cross-Sectional (n=51)
Yes
What are the present practices and criteria utilized by cardiologists regarding driving restrictions for patients with implanted cardioverter defibrillators?
There is significant variability among cardiologists in advising driving restrictions after ICD implantation, with many recommendations not based on knowledge of state laws.
Variability in post-ICD driving advice warrants caution; leaves open standardization aligned with state laws.
Although some patients remain at risk of losing physical control or collapsing after implantation of a cardioverter defibrillator for sustained ventricular arrhythmias, little is known about restrictions advised by arrhythmia specialists to patients with implanted devices concerning physical activities such as driving. In this study, all of the 58 cardiologists implanting cardioverter defibrillators in three contiguous midwestern states were surveyed to determine present practices and the compatibility of these practices with existing state law. Of the 51 respondents (88%), 27 cardiologists (53%) advised only those implanted patients who had had arrhythmia-induced presyncope or physical collapse to cease driving. Twenty two of the remaining cardiologists (43%) advised all implanted patients to cease driving, whereas two cardiologists (4%) never advised any implanted patient to restrict driving. Permanent driving abstinence was advised by seven of the responding cardiologists (14%), while temporary driving abstinence for periods of 2-12 months (mean 6 +/- 3 months) was recommended by the remaining 42 respondents (82%) who advised against driving. The criteria utilized, driving restrictions advised, and durations advised for driving restrictions were not uniform in any of the 13 surveyed university and nonaffiliated cardiology practices with greater than or equal to 2 implanting cardiologists. Overall, 38 cardiologists (74%) advised against driving and recommended durations that equaled or exceed their state's minimum legal requirements, although only 27 of the 51 cardiologists (53%) based their practice upon knowledge of their state's driving laws. The results of this survey suggest that the majority of cardiologists who implant cardioverter defibrillators advise their patients against driving postoperatively.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
DiCarlo et al. (1992) conducted a cross-sectional in Cardiologists implanting cardioverter defibrillators (n=51). Driving restriction advice practices was evaluated on Driving restriction advice practices. A survey of 51 cardiologists found that 53% advised driving cessation only for patients with arrhythmia-induced presyncope or collapse, while 43% advised all implanted patients to cease driving.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: